Page last updated: 2024-09-04

atrasentan and Elevated Cholesterol

atrasentan has been researched along with Elevated Cholesterol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Best, PJ; Bonetti, PO; Holmes, DR; Lerman, A; Lerman, LO; Rodriguez-Porcel, M1
Best, PJ; Chade, AR; Herrmann, J; Lerman, A; Lerman, LO; Napoli, C; Rodriguez-Porcel, M; Sawamura, T; Zhu, X1
Chade, AR; Krier, JD; Lerman, A; Lerman, LO; Textor, SC1
Best, PJ; Hasdai, D; Holmes, DR; Lerman, A; McKenna, CJ1

Other Studies

4 other study(ies) available for atrasentan and Elevated Cholesterol

ArticleYear
Endothelin type A receptor antagonism restores myocardial perfusion response to adenosine in experimental hypercholesterolemia.
    Atherosclerosis, 2003, Volume: 168, Issue:2

    Topics: Adenosine; Animals; Atrasentan; Body Weight; Capillary Permeability; Cholesterol, Dietary; Coronary Circulation; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Hemodynamics; Hypercholesterolemia; Lipids; Microcirculation; Protein Isoforms; Pyrrolidines; Swine

2003
Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia.
    Kidney international, 2003, Volume: 64, Issue:3

    Topics: Animals; Atrasentan; Body Fluids; Endothelin A Receptor Antagonists; Hemodynamics; Hypercholesterolemia; Kidney; Kidney Diseases; Oxidative Stress; Pyrrolidines; Renal Circulation; Swine

2003
Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia.
    Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:12

    Topics: Animals; Atrasentan; Blood Pressure; Disease Models, Animal; Endothelin A Receptor Antagonists; Glomerular Filtration Rate; Hypercholesterolemia; Imaging, Three-Dimensional; Kidney; Microcirculation; Pyrrolidines; Receptor, Angiotensin, Type 1; Renin; Sus scrofa; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A

2006
Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia.
    Circulation, 1999, Apr-06, Volume: 99, Issue:13

    Topics: Administration, Oral; Animals; Atrasentan; Bosentan; Coronary Vessels; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelium, Vascular; Hemodynamics; Hypercholesterolemia; Pyrrolidines; Random Allocation; Receptor, Endothelin A; Sulfonamides; Swine

1999